Oral JAK Inhibitor Plus Light Therapy May Boost Repigmentation Rates in Vitiligo: Study
Combining a Janus kinase (JAK) inhibitor with light therapy may enhance repigmentation for patients with nonsegmental vitiligo, according to a new study in in the Journal of the American Academy of Dermatology.